These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3701190)

  • 21. [Chelating therapy in beta-thalassemia].
    Musumeci S; Romeo MA; Di Gregorio F; Schiliró G; Russo G
    Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevalence, causes and effects of increased iron storage in patients with kidney transplantation].
    Holtmann G; Anlauf M; Wagner K; Holtmann M; Kölbel CB; Philipp T; Goebell H
    Med Klin (Munich); 1990 Sep; 85(9):517-22. PubMed ID: 2233609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic efficacy of tests for the detection of iron overload in chronic liver disease.
    Valberg LS; Ghent CN; Lloyd DA; Frei JV; Chamberlain MJ
    Can Med Assoc J; 1978 Aug; 119(3):229-36. PubMed ID: 679127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of subcutaneous desferrioxamine on iron balance in young thalassemia major patients.
    De Virgiliis S; Cossu P; Toccafondi C; Sanna G; Frau F; Lobrano R; Cornacchia G; Nucaro A; Loi A; Bertolino F; Cao A
    Am J Pediatr Hematol Oncol; 1983; 5(1):73-7. PubMed ID: 6859457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfusional iron overload: the relationship between tissue iron concentration and hepatic fibrosis in thalassaemia.
    Risdon RA; Barry M; Flynn DM
    J Pathol; 1975 Jun; 116(2):83-95. PubMed ID: 1151528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
    Daar S; Pathare AV
    Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of cardiac siderosis despite hepatic iron overload in Italian patients with thalassemia intermedia: an MRI T2* study.
    Roghi A; Cappellini MD; Wood JC; Musallam KM; Patrizia P; Fasulo MR; Cesaretti C; Taher AT
    Ann Hematol; 2010 Jun; 89(6):585-9. PubMed ID: 20016898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tired blood and rusty livers.
    Saltman P; Hegenauer J; Christopher J
    Ann Clin Lab Sci; 1976; 6(2):167-76. PubMed ID: 1252066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total body iron overload in welder's siderosis.
    Doherty MJ; Healy M; Richardson SG; Fisher NC
    Occup Environ Med; 2004 Jan; 61(1):82-5. PubMed ID: 14691279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one in thalassemia patients.
    Olivieri NF; Koren G; St Louis P; Freedman MH; McClelland RA; Templeton DM
    Semin Hematol; 1990 Apr; 27(2):101-4. PubMed ID: 2190316
    [No Abstract]   [Full Text] [Related]  

  • 31. Regulation of hepatic transferrin, transferrin receptor and ferritin genes in human siderosis.
    Pietrangelo A; Rocchi E; Ferrari A; Ventura E; Cairo G
    Hepatology; 1991 Dec; 14(6):1083-9. PubMed ID: 1959858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastric Glandular Siderosis but not Lamina Propria Siderosis is Associated With High Serum Ferritin Levels.
    Sarwate M; Khaitan N; Alpert L; Tavberidze N; Zhang W; Panarelli N; Hu S
    Am J Surg Pathol; 2023 Sep; 47(9):1052-1058. PubMed ID: 37357943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A
    Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased natural killer activity in thalassemia major: a possible consequence of iron overload.
    Akbar AN; Fitzgerald-Bocarsly PA; de Sousa M; Giardina PJ; Hilgartner MW; Grady RW
    J Immunol; 1986 Mar; 136(5):1635-40. PubMed ID: 3005397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating iron-containing macrophages in hemochromatosis.
    Yam LT; Finkel HE; Weintraub LR; Crosby WH
    N Engl J Med; 1968 Sep; 279(10):512-4. PubMed ID: 5671456
    [No Abstract]   [Full Text] [Related]  

  • 36. [Disturbancies of iron utilization: chronic anaemia, sideroblastic anaemia, and residual endothelial siderosis (author's transl)].
    Hausmann K
    Haematol Blood Transfus; 1978; 21():145-61. PubMed ID: 738633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of iron overload in thalassemia.
    Cianciulli P
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():208-13. PubMed ID: 19337180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.
    McLaren GD; Muir WA; Kellermeyer RW
    Crit Rev Clin Lab Sci; 1983; 19(3):205-66. PubMed ID: 6373141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral iron chelating therapy. A single center interim report on deferiprone (L1) in thalassemia.
    Mazza P; Amurri B; Lazzari G; Masi C; Palazzo G; Spartera MA; Giua R; Sebastio AM; Suma V; De Marco S; Semeraro F; Moscogiuri R
    Haematologica; 1998 Jun; 83(6):496-501. PubMed ID: 9676021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T2 relaxation rate as an index of pituitary iron overload in patients with beta-thalassemia major.
    Argyropoulou MI; Metafratzi Z; Kiortsis DN; Bitsis S; Tsatsoulis A; Efremidis S
    AJR Am J Roentgenol; 2000 Dec; 175(6):1567-9. PubMed ID: 11090376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.